Alpha Crest Capital Management LLC Ligand Pharmaceuticals Inc Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $431,989 - $568,746	-5,363 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$89.56 - $126.72 $480,310 - $679,599	5,363 New	5,363 $511,000
Q2 2020 Aug 12, 2020	SELL	$68.28 - $123.65 $247,310 - $447,860	-3,622 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$63.37 - $107.88 $229,526 - $390,741	3,622 New	3,622 $263,000
Q4 2019 Feb 12, 2020	SELL	$96.94 - $113.59 $372,540 - $436,526	-3,843 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$86.25 - $120.16 $331,458 - $461,774	3,843 New	3,843 $383,000
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $240,960 - $290,238	-2,244 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$105.93 - $142.47 $237,706 - $319,702	2,244 New	2,244 $282,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.